• reMYND announces Clinical Advisory Board to support development of Alzheimer’s programme

    Thursday May 20th 2021

  • Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks

    Thursday May 20th 2021

  • Pathomation announces the support for five new digital pathology file formats, including Philips iSyntax

    Tuesday May 18th 2021

  • Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance

    Tuesday May 11th 2021

  • CD3 and VIB enter into an exclusive license and research collaboration with SpringWorks Therapeutics to develop TEAD inhibitors for addressing biomarker-defined cancers

    Friday May 7th 2021

  • Latest Neuropixels probes can track neurons over weeks

    Friday April 16th 2021

  • Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD integrin antagonists to improve the treatment of diabetic retinopathy and wet AMD

    Thursday April 8th 2021

  • Complix and VIB publish pioneering study on Cell-Penetrating Alphabodies in Science Advances

    Wednesday March 31st 2021

  • Your news here?

  • Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases

    Tuesday March 23rd 2021

  • ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version

    Monday March 22nd 2021

  • Biocartis launches Idylla™ GeneFusion Assay as rapid lab workflow solution for gene fusion testing

    Monday March 22nd 2021


Strategic Partners